About
ClotProtect is developing a first-in-class small molecule anti-fibrinolytic therapeutic aimed at treating acute bleeding by promoting clot formation more effectively than current treatments.
Explore ClotProtect's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.